Focus on the illnesses that have the most impact
CICM was appointed by the ministry of public health as the national reference laboratory (NRL) for the monitoring of resistance to anti-leprosy treatments in 2017; it diagnoses and studies the resistance of cases of leprosy consulting the dermatology treatment and research centre of JRB university hospital, as well as cases reported in other regions.
To verify the efficacy of antiretroviral treatment, the national reference laboratory of the ministry of public health performs HIV viral load tests (HIV VL) but this activity was suspended in 2012. In 2015, CICM set up an open platform to evaluate HIV VL, supported by the Mérieux Foundation.
This activity aims to reinforce laboratory capacities and extend the availability of this analysis to all patients, while also helping to reach the 3rd UNAIDS 90 target in 2020. This activity aims to build the national capacities of the NRL and CICM to perform HIV viral load tests throughout the country. CICM is maintaining the HIV viral load activity until the NRL takes over.
This is a study of the detection of the etiological agents of meningitis and/or meningoencephalitis in children admitted to the Tsaralalàna mother and child university hospital, using FilmArray®System respiratory/encephalitis panels (donated by the Mérieux Foundation USA). The main goal is to compare the results of bacteria identification obtained by microscope/culture (gold standard) with those of the FilmArray®Meningitis/Encephalitis panel.